APIXABAN

作品数：24被引量：38H指数：4
导出分析报告
相关领域：医药卫生更多>>
相关作者：王永辉高渊孔蕾更多>>
相关机构：华东师范大学第四军医大学唐都医院中国医科大学附属第一医院更多>>
相关期刊：《American Journal of Analytical Chemistry》《心脏杂志》《药学进展》《World Journal of Gastroenterology》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Spontaneous Coronary Artery Disease in a Healthy Fibromuscular Dysplasia Patient: A Case Report
《Case Reports in Clinical Medicine》2024年第9期375-381,共7页Munir Shunnar Obada Alshaikh Maha Alzubaidi Hyun-Ryung Choi 
Our case is a 72-year-old female with Fibromuscular Dysplasia (FMD) presented to the Emergency Department (ED) with acute coronary syndrome (ACS), more specifically NSTEMI. In ED, troponin levels were elevated and non...
关键词：SCAD NSTEMI STEMI ACS Eliquis PSEUDOANEURYSM Fibromuscular Dysplasia ANTICOAGULANT ANTIPLATELET Coronary Dissection Neuroendovascular Cardiology WARFARIN Cath Lab APIXABAN Clopidogrel 
Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease
《World Journal of Nephrology》2023年第5期132-146,共15页Sylvie Perreault Laurie-Anne Boivin Proulx Aurélie Lenglet Ziad A Massy Marc Dorais 
BACKGROUND Randomized controlled trials(RCTs)of direct oral anticoagulants(DOACs)included a low proportion of atrial fibrillation(AF)patients with chronic kidney disease(CKD),and suggested that DOACs are safe and effe...
关键词：Atrial fibrillation Chronic kidney disease Direct oral anticoagulant EFFECTIVENESS SAFETY WARFARIN 
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
《Journal of Molecular Cell Biology》2022年第6期68-71,共4页Otávio Augusto Chaves Carolina Q.Sacramento Natalia Fintelman-Rodrigues Jairo Ramos Temerozo Filipe Pereira-Dutra Daniella M.Mizurini Robson Q.Monteiro Leonardo Vazquez Patricia T.Bozza Hugo Caire Castro-Faria-Neto Thiago Moreno L.Souza 
Dear Editor,The severe coronavirus disease 2019(COVID-19)is associated with coagulopathy.Anticoagulants,such as low-molecular-weight heparin,warfarin,thrombin inhibitors,and factor Xa(FXa)inhibitors,are thus recommend...
关键词：al. Clinical HEPARIN 
Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis:What is the evidence?被引量：4
《World Journal of Hepatology》2022年第4期682-695,共14页Marco Biolato Mattia Paratore Luca Di Gialleonardo Giuseppe Marrone Antonio Grieco 
In recent years,the traditional concept that cirrhosis-related coagulopathy is an acquired bleeding disorder has evolved.Currently,it is known that in cirrhotic patients,the hemostatic system is rebalanced,which invol...
关键词：DABIGATRAN RIVAROXABAN APIXABAN EDOXABAN BLEEDING 
Dabigatran,rivaroxaban,and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation:An updated metaanalysis被引量：5
《World Journal of Cardiology》2021年第4期82-94,共13页Wei-Jia Li Paraschos Archontakis-Barakakis Leonidas Palaiodimos Dimitrios Kalaitzoglou Lazaros Tzelves Apostolos Manolopoulos Yu-Chiang Wang Stefanos Giannopoulos Robert Faillace Damianos G Kokkinidis 
BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation(AF)originated from western countrie...
关键词：Novel oral anticoagulant Direct oral anticoagulant Atrial fibrillation Asian population DABIGATRAN RIVAROXABAN APIXABAN WARFARIN 
Prevalence and clinical characteristics associated with left atrial thrombus detection: Apixaban被引量：3
《World Journal of Cardiology》2019年第2期84-93,共10页Hoyle L Whiteside Arun Nagabandi Kristen Brown Deepak N Ayyala Gyanendra K Sharma 
BACKGROUND The prevalence of left atrial appendage(LAA) thrombus detection by transesophageal echocardiogram(TEE) in patients with non-valvular atrial fibrillation(AF) anticoagulated with apixaban is not well defined ...
关键词：ATRIAL FIBRILLATION ANTICOAGULATION Left ATRIAL appendage THROMBUS TRANSESOPHAGEAL echocardiography 
Laboratory Tests in Assessing the Bleeding Risk in Patients Receiving Direct Oral Anticoagulants (DOACs)
《World Journal of Cardiovascular Diseases》2018年第5期257-264,共8页Subhash Edupuganti Mary Wyrzykowski Elizabeth Wey Ming Xie 
Direct oral anticoagulants (DOACs)—apixaban, rivaroxaban and dabigatran have become the first line medications for patients with thromboembolism. However, DOAC therapy-associated bleeding complications remain the maj...
关键词：DIRECT Oral Anticoagulants Prothrombin TIME Partial THROMBOPLASTIN TIME APIXABAN RIVAROXABAN DABIGATRAN Bleeding Complications 
Gastrointestinal bleeding in patients on novel oral anticoagulants:Risk,prevention and management被引量：9
《World Journal of Gastroenterology》2017年第11期1954-1963,共10页Ka-Shing Cheung Wai K Leung 
Supported by the Li Shu Fan Medical Foundation Professorship(to Leung WK)
Novel oral anticoagulants(NOACs), which include direct thrombin inhibitor(dabigatran) and direct factor Xa inhibitors(rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention of embolic stroke in ...
关键词：WARFARIN ENDOSCOPY APIXABAN EDOXABAN Gastrointestinal bleeding DABIGATRAN RIVAROXABAN Novel anticoagulants 
Development and Validation of Stability Indicating RP-HPLC Method on Core Shell Column for Determination of Degradation and Process Related Impurities of Apixaban—An Anticoagulant Drug被引量：2
《American Journal of Analytical Chemistry》2015年第6期539-550,共12页Shashikant B. Landge Sanjay A. Jadhav Sunil B. Dahale Pavankumar V. Solanki Saroj R. Bembalkar Vijayavitthal T. Mathad 
A rapid, specific, sensitive, and precise reverse-phase HPLC method for the quantitative determination of process related and degradation impurities of Apixaban, an anticoagulant drug is described. The developed RP-HP...
关键词：APIXABAN CORE-SHELL HPLC COLUMNS RSD and VALIDATION Stability Indicating 
Monitoring anticoagulant therapy with new oral agents被引量：1
《World Journal of Methodology》2015年第4期212-215,共4页Allan Ramos-Esquivel 
Thromboembolic disease is a major leading cause of mortality and morbidity in industrialized countries. Currently, the management of these patients is challenging due to the availability of new drugs with proven effic...
关键词：ANTICOAGULANT agents APIXABAN DABIGATRAN DRUG MONITORING RIVAROXABAN 
全选清除导出
共3页<123>
检索报告 对象比较 聚类工具 使用帮助 返回顶部